Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ Investing
4 stocks to protect you from a falling Aussie dollar
⏸️ Investing
Get on the road-to-riches with these 3 top growth stocks
⏸️ Investing
CSL Limited, Commonwealth Bank of Australia or Cochlear Limited: Which ASX stock will hit $100 first?
⏸️ Investing
Buy these stocks to profit from an Australian dollar that may fall below US 70 cents
⏸️ Investing
Here's how you beat the market
⏸️ Investing
2 of the best mid-caps to own in 2015
⏸️ Investing
Beat the experts with these 4 ASX stocks
⏸️ Investing
Telstra Corporation Ltd and Cochlear Limited: 2 stocks for solid growth in 2015
⏸️ Investing
4 examples of why owning quality stocks could be your best bet in 2015
⏸️ Investing
4 great blue-chip stocks to benefit from a falling AUD
⏸️ Investing
2 healthcare stocks you need to keep your portfolio in tip-top shape for 2015
⏸️ Investing
Here's how you can profit from the falling Australian dollar
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
